Global Famitinib Malate Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Famitinib Malate Capsules market size was valued at US$ 10.70 million in 2025 and is forecast to a readjusted size of US$ 42.99 million by 2032 with a CAGR of 6.2% during review period.
Famitinib malate is an oral multi-target tyrosine kinase inhibitor that mainly acts on various kinase targets such as VEGFR, PDGFR, and c-Kit. It exerts anti-tumor effects by inhibiting tumor angiogenesis and blocking signal transduction for tumor cell proliferation. Formulated as oral capsules in the form of malate salt, it is mainly used clinically for the treatment of advanced or metastatic solid tumors. It is often combined with immune checkpoint inhibitors to improve therapeutic efficacy. Characterized by a broad target spectrum, convenient oral administration, and a wide anti-tumor range, it has clear clinical application value in gynecological tumors, gastrointestinal tumors and other fields.In 2025, global production of Famitinib Malate Capsules reached approximately 1.2 million bottles.
Famitinib malate, a Class 1 innovative drug independently developed by Hengrui Medicine, is the world's first multi-target tyrosine kinase inhibitor approved for the treatment of cervical cancer. Centered on the targeted-immunotherapy regimen in combination with camrelizumab, it fills a key gap in the second-line treatment of recurrent or metastatic cervical cancer. Positioned for patients who have not received bevacizumab, it has formed differentiated competitiveness in the domestic cervical cancer treatment field thanks to its convenient oral administration, broad target coverage and remarkable efficacy. Following its inclusion in the National Reimbursement Drug List at the end of 2025, treatment costs dropped significantly, patient accessibility improved substantially, and clinical penetration accelerated. In the current market landscape, as the only domestically approved targeted-immunotherapy combination regimen for cervical cancer, famitinib competes with imported anti-angiogenic agents, domestic similar TKIs and bispecific antibodies. It holds a core position in second-line treatment by virtue of its medical insurance advantages, local R&D strengths and superior survival benefit data. Meanwhile, its ongoing research covers first-line cervical cancer and other solid tumors, which is expected to further expand its market space and consolidate its leading position in the field of oncology therapy.
This report is a detailed and comprehensive analysis for global Famitinib Malate Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Famitinib Malate Capsules market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Famitinib Malate Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Famitinib Malate Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Famitinib Malate Capsules, with price, sales quantity, revenue, and global market share of Famitinib Malate Capsules from 2021 to 2026.
Chapter 3, the Famitinib Malate Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Famitinib Malate Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Famitinib Malate Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Famitinib Malate Capsules.
Chapter 14 and 15, to describe Famitinib Malate Capsules sales channel, distributors, customers, research findings and conclusion.
Famitinib malate is an oral multi-target tyrosine kinase inhibitor that mainly acts on various kinase targets such as VEGFR, PDGFR, and c-Kit. It exerts anti-tumor effects by inhibiting tumor angiogenesis and blocking signal transduction for tumor cell proliferation. Formulated as oral capsules in the form of malate salt, it is mainly used clinically for the treatment of advanced or metastatic solid tumors. It is often combined with immune checkpoint inhibitors to improve therapeutic efficacy. Characterized by a broad target spectrum, convenient oral administration, and a wide anti-tumor range, it has clear clinical application value in gynecological tumors, gastrointestinal tumors and other fields.In 2025, global production of Famitinib Malate Capsules reached approximately 1.2 million bottles.
Famitinib malate, a Class 1 innovative drug independently developed by Hengrui Medicine, is the world's first multi-target tyrosine kinase inhibitor approved for the treatment of cervical cancer. Centered on the targeted-immunotherapy regimen in combination with camrelizumab, it fills a key gap in the second-line treatment of recurrent or metastatic cervical cancer. Positioned for patients who have not received bevacizumab, it has formed differentiated competitiveness in the domestic cervical cancer treatment field thanks to its convenient oral administration, broad target coverage and remarkable efficacy. Following its inclusion in the National Reimbursement Drug List at the end of 2025, treatment costs dropped significantly, patient accessibility improved substantially, and clinical penetration accelerated. In the current market landscape, as the only domestically approved targeted-immunotherapy combination regimen for cervical cancer, famitinib competes with imported anti-angiogenic agents, domestic similar TKIs and bispecific antibodies. It holds a core position in second-line treatment by virtue of its medical insurance advantages, local R&D strengths and superior survival benefit data. Meanwhile, its ongoing research covers first-line cervical cancer and other solid tumors, which is expected to further expand its market space and consolidate its leading position in the field of oncology therapy.
This report is a detailed and comprehensive analysis for global Famitinib Malate Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Famitinib Malate Capsules market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Famitinib Malate Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Famitinib Malate Capsules
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Famitinib Malate Capsules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 5 mg per capsule
- 10 mg per capsule
- Camrelizumab
- Chemotherapeutic Agents
- Innovator
- Generic
- Hospital
- Retail
- Online
- Recurrent or Metastatic Cervical Cancer
- Advanced Gastrointestinal Tumors
- Other Advanced Solid Tumors
- Jiangsu Hengrui Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Famitinib Malate Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Famitinib Malate Capsules, with price, sales quantity, revenue, and global market share of Famitinib Malate Capsules from 2021 to 2026.
Chapter 3, the Famitinib Malate Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Famitinib Malate Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Famitinib Malate Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Famitinib Malate Capsules.
Chapter 14 and 15, to describe Famitinib Malate Capsules sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Famitinib Malate Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5 mg per capsule
1.3.3 10 mg per capsule
1.4 Market Analysis by Combination Therapy
1.4.1 Overview: Global Famitinib Malate Capsules Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
1.4.2 Camrelizumab
1.4.3 Chemotherapeutic Agents
1.5 Market Analysis by Production Technology
1.5.1 Overview: Global Famitinib Malate Capsules Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
1.5.2 Innovator
1.5.3 Generic
1.6 Market Analysis by Sales Channels
1.6.1 Overview: Global Famitinib Malate Capsules Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Retail
1.6.4 Online
1.7 Market Analysis by Application
1.7.1 Overview: Global Famitinib Malate Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Recurrent or Metastatic Cervical Cancer
1.7.3 Advanced Gastrointestinal Tumors
1.7.4 Other Advanced Solid Tumors
1.8 Global Famitinib Malate Capsules Market Size & Forecast
1.8.1 Global Famitinib Malate Capsules Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Famitinib Malate Capsules Sales Quantity (2021-2032)
1.8.3 Global Famitinib Malate Capsules Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Jiangsu Hengrui Pharmaceutical
2.1.1 Jiangsu Hengrui Pharmaceutical Details
2.1.2 Jiangsu Hengrui Pharmaceutical Major Business
2.1.3 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product and Services
2.1.4 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FAMITINIB MALATE CAPSULES BY MANUFACTURER
3.1 Global Famitinib Malate Capsules Sales Quantity by Manufacturer (2021-2026)
3.2 Global Famitinib Malate Capsules Revenue by Manufacturer (2021-2026)
3.3 Global Famitinib Malate Capsules Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Famitinib Malate Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Famitinib Malate Capsules Manufacturer Market Share in 2025
3.4.3 Top 6 Famitinib Malate Capsules Manufacturer Market Share in 2025
3.5 Famitinib Malate Capsules Market: Overall Company Footprint Analysis
3.5.1 Famitinib Malate Capsules Market: Region Footprint
3.5.2 Famitinib Malate Capsules Market: Company Product Type Footprint
3.5.3 Famitinib Malate Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Famitinib Malate Capsules Market Size by Region
4.1.1 Global Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
4.1.2 Global Famitinib Malate Capsules Consumption Value by Region (2021-2032)
4.1.3 Global Famitinib Malate Capsules Average Price by Region (2021-2032)
4.2 North America Famitinib Malate Capsules Consumption Value (2021-2032)
4.3 Europe Famitinib Malate Capsules Consumption Value (2021-2032)
4.4 Asia-Pacific Famitinib Malate Capsules Consumption Value (2021-2032)
4.5 South America Famitinib Malate Capsules Consumption Value (2021-2032)
4.6 Middle East & Africa Famitinib Malate Capsules Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
5.2 Global Famitinib Malate Capsules Consumption Value by Type (2021-2032)
5.3 Global Famitinib Malate Capsules Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
6.2 Global Famitinib Malate Capsules Consumption Value by Application (2021-2032)
6.3 Global Famitinib Malate Capsules Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
7.2 North America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
7.3 North America Famitinib Malate Capsules Market Size by Country
7.3.1 North America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
7.3.2 North America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
8.2 Europe Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
8.3 Europe Famitinib Malate Capsules Market Size by Country
8.3.1 Europe Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
8.3.2 Europe Famitinib Malate Capsules Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Famitinib Malate Capsules Market Size by Region
9.3.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
10.2 South America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
10.3 South America Famitinib Malate Capsules Market Size by Country
10.3.1 South America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
10.3.2 South America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Famitinib Malate Capsules Market Size by Country
11.3.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Famitinib Malate Capsules Market Drivers
12.2 Famitinib Malate Capsules Market Restraints
12.3 Famitinib Malate Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Famitinib Malate Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Famitinib Malate Capsules
13.3 Famitinib Malate Capsules Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Famitinib Malate Capsules Typical Distributors
14.3 Famitinib Malate Capsules Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Famitinib Malate Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5 mg per capsule
1.3.3 10 mg per capsule
1.4 Market Analysis by Combination Therapy
1.4.1 Overview: Global Famitinib Malate Capsules Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
1.4.2 Camrelizumab
1.4.3 Chemotherapeutic Agents
1.5 Market Analysis by Production Technology
1.5.1 Overview: Global Famitinib Malate Capsules Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
1.5.2 Innovator
1.5.3 Generic
1.6 Market Analysis by Sales Channels
1.6.1 Overview: Global Famitinib Malate Capsules Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
1.6.2 Hospital
1.6.3 Retail
1.6.4 Online
1.7 Market Analysis by Application
1.7.1 Overview: Global Famitinib Malate Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Recurrent or Metastatic Cervical Cancer
1.7.3 Advanced Gastrointestinal Tumors
1.7.4 Other Advanced Solid Tumors
1.8 Global Famitinib Malate Capsules Market Size & Forecast
1.8.1 Global Famitinib Malate Capsules Consumption Value (2021 & 2025 & 2032)
1.8.2 Global Famitinib Malate Capsules Sales Quantity (2021-2032)
1.8.3 Global Famitinib Malate Capsules Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Jiangsu Hengrui Pharmaceutical
2.1.1 Jiangsu Hengrui Pharmaceutical Details
2.1.2 Jiangsu Hengrui Pharmaceutical Major Business
2.1.3 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product and Services
2.1.4 Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: FAMITINIB MALATE CAPSULES BY MANUFACTURER
3.1 Global Famitinib Malate Capsules Sales Quantity by Manufacturer (2021-2026)
3.2 Global Famitinib Malate Capsules Revenue by Manufacturer (2021-2026)
3.3 Global Famitinib Malate Capsules Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Famitinib Malate Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Famitinib Malate Capsules Manufacturer Market Share in 2025
3.4.3 Top 6 Famitinib Malate Capsules Manufacturer Market Share in 2025
3.5 Famitinib Malate Capsules Market: Overall Company Footprint Analysis
3.5.1 Famitinib Malate Capsules Market: Region Footprint
3.5.2 Famitinib Malate Capsules Market: Company Product Type Footprint
3.5.3 Famitinib Malate Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Famitinib Malate Capsules Market Size by Region
4.1.1 Global Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
4.1.2 Global Famitinib Malate Capsules Consumption Value by Region (2021-2032)
4.1.3 Global Famitinib Malate Capsules Average Price by Region (2021-2032)
4.2 North America Famitinib Malate Capsules Consumption Value (2021-2032)
4.3 Europe Famitinib Malate Capsules Consumption Value (2021-2032)
4.4 Asia-Pacific Famitinib Malate Capsules Consumption Value (2021-2032)
4.5 South America Famitinib Malate Capsules Consumption Value (2021-2032)
4.6 Middle East & Africa Famitinib Malate Capsules Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
5.2 Global Famitinib Malate Capsules Consumption Value by Type (2021-2032)
5.3 Global Famitinib Malate Capsules Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
6.2 Global Famitinib Malate Capsules Consumption Value by Application (2021-2032)
6.3 Global Famitinib Malate Capsules Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
7.2 North America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
7.3 North America Famitinib Malate Capsules Market Size by Country
7.3.1 North America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
7.3.2 North America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
8.2 Europe Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
8.3 Europe Famitinib Malate Capsules Market Size by Country
8.3.1 Europe Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
8.3.2 Europe Famitinib Malate Capsules Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Famitinib Malate Capsules Market Size by Region
9.3.1 Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
10.2 South America Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
10.3 South America Famitinib Malate Capsules Market Size by Country
10.3.1 South America Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
10.3.2 South America Famitinib Malate Capsules Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Famitinib Malate Capsules Market Size by Country
11.3.1 Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Famitinib Malate Capsules Market Drivers
12.2 Famitinib Malate Capsules Market Restraints
12.3 Famitinib Malate Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Famitinib Malate Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Famitinib Malate Capsules
13.3 Famitinib Malate Capsules Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Famitinib Malate Capsules Typical Distributors
14.3 Famitinib Malate Capsules Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Famitinib Malate Capsules Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Famitinib Malate Capsules Consumption Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 3. Global Famitinib Malate Capsules Consumption Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 4. Global Famitinib Malate Capsules Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 5. Global Famitinib Malate Capsules Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 7. Jiangsu Hengrui Pharmaceutical Major Business
Table 8. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product and Services
Table 9. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
Table 11. Global Famitinib Malate Capsules Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 12. Global Famitinib Malate Capsules Revenue by Manufacturer (2021-2026) & (USD Million)
Table 13. Global Famitinib Malate Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 14. Market Position of Manufacturers in Famitinib Malate Capsules, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 15. Head Office and Famitinib Malate Capsules Production Site of Key Manufacturer
Table 16. Famitinib Malate Capsules Market: Company Product Type Footprint
Table 17. Famitinib Malate Capsules Market: Company Product Application Footprint
Table 18. Famitinib Malate Capsules New Market Entrants and Barriers to Market Entry
Table 19. Famitinib Malate Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 20. Global Famitinib Malate Capsules Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 21. Global Famitinib Malate Capsules Sales Quantity by Region (2021-2026) & (Units)
Table 22. Global Famitinib Malate Capsules Sales Quantity by Region (2027-2032) & (Units)
Table 23. Global Famitinib Malate Capsules Consumption Value by Region (2021-2026) & (USD Million)
Table 24. Global Famitinib Malate Capsules Consumption Value by Region (2027-2032) & (USD Million)
Table 25. Global Famitinib Malate Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 26. Global Famitinib Malate Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 27. Global Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 28. Global Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 29. Global Famitinib Malate Capsules Consumption Value by Type (2021-2026) & (USD Million)
Table 30. Global Famitinib Malate Capsules Consumption Value by Type (2027-2032) & (USD Million)
Table 31. Global Famitinib Malate Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 32. Global Famitinib Malate Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 33. Global Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 34. Global Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 35. Global Famitinib Malate Capsules Consumption Value by Application (2021-2026) & (USD Million)
Table 36. Global Famitinib Malate Capsules Consumption Value by Application (2027-2032) & (USD Million)
Table 37. Global Famitinib Malate Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 38. Global Famitinib Malate Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 39. North America Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 40. North America Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 41. North America Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 42. North America Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 43. North America Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 44. North America Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 45. North America Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 46. North America Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 47. Europe Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 48. Europe Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 49. Europe Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 50. Europe Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 51. Europe Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 52. Europe Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 53. Europe Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 54. Europe Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 55. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 56. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 57. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 58. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 59. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2021-2026) & (Units)
Table 60. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2027-2032) & (Units)
Table 61. Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2027-2032) & (USD Million)
Table 63. South America Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 64. South America Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 65. South America Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 66. South America Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 67. South America Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 68. South America Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 69. South America Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 70. South America Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 71. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 73. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 74. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 75. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 76. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 77. Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Famitinib Malate Capsules Raw Material
Table 80. Key Manufacturers of Famitinib Malate Capsules Raw Materials
Table 81. Famitinib Malate Capsules Typical Distributors
Table 82. Famitinib Malate Capsules Typical Customers
Table 1. Global Famitinib Malate Capsules Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Famitinib Malate Capsules Consumption Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 3. Global Famitinib Malate Capsules Consumption Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 4. Global Famitinib Malate Capsules Consumption Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 5. Global Famitinib Malate Capsules Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 7. Jiangsu Hengrui Pharmaceutical Major Business
Table 8. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Product and Services
Table 9. Jiangsu Hengrui Pharmaceutical Famitinib Malate Capsules Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
Table 11. Global Famitinib Malate Capsules Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 12. Global Famitinib Malate Capsules Revenue by Manufacturer (2021-2026) & (USD Million)
Table 13. Global Famitinib Malate Capsules Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 14. Market Position of Manufacturers in Famitinib Malate Capsules, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 15. Head Office and Famitinib Malate Capsules Production Site of Key Manufacturer
Table 16. Famitinib Malate Capsules Market: Company Product Type Footprint
Table 17. Famitinib Malate Capsules Market: Company Product Application Footprint
Table 18. Famitinib Malate Capsules New Market Entrants and Barriers to Market Entry
Table 19. Famitinib Malate Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 20. Global Famitinib Malate Capsules Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 21. Global Famitinib Malate Capsules Sales Quantity by Region (2021-2026) & (Units)
Table 22. Global Famitinib Malate Capsules Sales Quantity by Region (2027-2032) & (Units)
Table 23. Global Famitinib Malate Capsules Consumption Value by Region (2021-2026) & (USD Million)
Table 24. Global Famitinib Malate Capsules Consumption Value by Region (2027-2032) & (USD Million)
Table 25. Global Famitinib Malate Capsules Average Price by Region (2021-2026) & (US$/Unit)
Table 26. Global Famitinib Malate Capsules Average Price by Region (2027-2032) & (US$/Unit)
Table 27. Global Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 28. Global Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 29. Global Famitinib Malate Capsules Consumption Value by Type (2021-2026) & (USD Million)
Table 30. Global Famitinib Malate Capsules Consumption Value by Type (2027-2032) & (USD Million)
Table 31. Global Famitinib Malate Capsules Average Price by Type (2021-2026) & (US$/Unit)
Table 32. Global Famitinib Malate Capsules Average Price by Type (2027-2032) & (US$/Unit)
Table 33. Global Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 34. Global Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 35. Global Famitinib Malate Capsules Consumption Value by Application (2021-2026) & (USD Million)
Table 36. Global Famitinib Malate Capsules Consumption Value by Application (2027-2032) & (USD Million)
Table 37. Global Famitinib Malate Capsules Average Price by Application (2021-2026) & (US$/Unit)
Table 38. Global Famitinib Malate Capsules Average Price by Application (2027-2032) & (US$/Unit)
Table 39. North America Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 40. North America Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 41. North America Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 42. North America Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 43. North America Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 44. North America Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 45. North America Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 46. North America Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 47. Europe Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 48. Europe Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 49. Europe Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 50. Europe Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 51. Europe Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 52. Europe Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 53. Europe Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 54. Europe Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 55. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 56. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 57. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 58. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 59. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2021-2026) & (Units)
Table 60. Asia-Pacific Famitinib Malate Capsules Sales Quantity by Region (2027-2032) & (Units)
Table 61. Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Famitinib Malate Capsules Consumption Value by Region (2027-2032) & (USD Million)
Table 63. South America Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 64. South America Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 65. South America Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 66. South America Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 67. South America Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 68. South America Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 69. South America Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 70. South America Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 71. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Type (2027-2032) & (Units)
Table 73. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2021-2026) & (Units)
Table 74. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Application (2027-2032) & (Units)
Table 75. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2021-2026) & (Units)
Table 76. Middle East & Africa Famitinib Malate Capsules Sales Quantity by Country (2027-2032) & (Units)
Table 77. Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Famitinib Malate Capsules Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Famitinib Malate Capsules Raw Material
Table 80. Key Manufacturers of Famitinib Malate Capsules Raw Materials
Table 81. Famitinib Malate Capsules Typical Distributors
Table 82. Famitinib Malate Capsules Typical Customers
LIST OF FIGURES
Figure 1. Famitinib Malate Capsules Picture
Figure 2. Global Famitinib Malate Capsules Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Famitinib Malate Capsules Revenue Market Share by Type in 2025
Figure 4. 5 mg per capsule Examples
Figure 5. 10 mg per capsule Examples
Figure 6. Global Famitinib Malate Capsules Revenue by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy in 2025
Figure 8. Camrelizumab Examples
Figure 9. Chemotherapeutic Agents Examples
Figure 10. Global Famitinib Malate Capsules Revenue by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Famitinib Malate Capsules Revenue Market Share by Production Technology in 2025
Figure 12. Innovator Examples
Figure 13. Generic Examples
Figure 14. Global Famitinib Malate Capsules Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels in 2025
Figure 16. Hospital Examples
Figure 17. Retail Examples
Figure 18. Online Examples
Figure 19. Global Famitinib Malate Capsules Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Famitinib Malate Capsules Revenue Market Share by Application in 2025
Figure 21. Recurrent or Metastatic Cervical Cancer Examples
Figure 22. Advanced Gastrointestinal Tumors Examples
Figure 23. Other Advanced Solid Tumors Examples
Figure 24. Global Famitinib Malate Capsules Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Famitinib Malate Capsules Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Famitinib Malate Capsules Sales Quantity (2021-2032) & (Units)
Figure 27. Global Famitinib Malate Capsules Price (2021-2032) & (US$/Unit)
Figure 28. Global Famitinib Malate Capsules Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Famitinib Malate Capsules Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Famitinib Malate Capsules by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Famitinib Malate Capsules Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Famitinib Malate Capsules Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Famitinib Malate Capsules Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Famitinib Malate Capsules Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Famitinib Malate Capsules Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Famitinib Malate Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. Global Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Famitinib Malate Capsules Revenue Market Share by Application (2021-2032)
Figure 45. Global Famitinib Malate Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 46. North America Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 58. France Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Famitinib Malate Capsules Consumption Value Market Share by Region (2021-2032)
Figure 66. China Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 69. India Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 86. Famitinib Malate Capsules Market Drivers
Figure 87. Famitinib Malate Capsules Market Restraints
Figure 88. Famitinib Malate Capsules Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Famitinib Malate Capsules in 2025
Figure 91. Manufacturing Process Analysis of Famitinib Malate Capsules
Figure 92. Famitinib Malate Capsules Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
Figure 1. Famitinib Malate Capsules Picture
Figure 2. Global Famitinib Malate Capsules Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Famitinib Malate Capsules Revenue Market Share by Type in 2025
Figure 4. 5 mg per capsule Examples
Figure 5. 10 mg per capsule Examples
Figure 6. Global Famitinib Malate Capsules Revenue by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Famitinib Malate Capsules Revenue Market Share by Combination Therapy in 2025
Figure 8. Camrelizumab Examples
Figure 9. Chemotherapeutic Agents Examples
Figure 10. Global Famitinib Malate Capsules Revenue by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Famitinib Malate Capsules Revenue Market Share by Production Technology in 2025
Figure 12. Innovator Examples
Figure 13. Generic Examples
Figure 14. Global Famitinib Malate Capsules Revenue by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Famitinib Malate Capsules Revenue Market Share by Sales Channels in 2025
Figure 16. Hospital Examples
Figure 17. Retail Examples
Figure 18. Online Examples
Figure 19. Global Famitinib Malate Capsules Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 20. Global Famitinib Malate Capsules Revenue Market Share by Application in 2025
Figure 21. Recurrent or Metastatic Cervical Cancer Examples
Figure 22. Advanced Gastrointestinal Tumors Examples
Figure 23. Other Advanced Solid Tumors Examples
Figure 24. Global Famitinib Malate Capsules Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Famitinib Malate Capsules Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Famitinib Malate Capsules Sales Quantity (2021-2032) & (Units)
Figure 27. Global Famitinib Malate Capsules Price (2021-2032) & (US$/Unit)
Figure 28. Global Famitinib Malate Capsules Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Famitinib Malate Capsules Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Famitinib Malate Capsules by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Famitinib Malate Capsules Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Famitinib Malate Capsules Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Famitinib Malate Capsules Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Famitinib Malate Capsules Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Famitinib Malate Capsules Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Famitinib Malate Capsules Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. Global Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Famitinib Malate Capsules Revenue Market Share by Application (2021-2032)
Figure 45. Global Famitinib Malate Capsules Average Price by Application (2021-2032) & (US$/Unit)
Figure 46. North America Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 58. France Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Famitinib Malate Capsules Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Famitinib Malate Capsules Consumption Value Market Share by Region (2021-2032)
Figure 66. China Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 69. India Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Famitinib Malate Capsules Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Famitinib Malate Capsules Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Famitinib Malate Capsules Consumption Value (2021-2032) & (USD Million)
Figure 86. Famitinib Malate Capsules Market Drivers
Figure 87. Famitinib Malate Capsules Market Restraints
Figure 88. Famitinib Malate Capsules Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Famitinib Malate Capsules in 2025
Figure 91. Manufacturing Process Analysis of Famitinib Malate Capsules
Figure 92. Famitinib Malate Capsules Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
